Results of a randomized phase III study of Nimotuzumab in combination with concurrent radiotherapy and Cisplatin versus radiotherapy and Cisplatin alone, in locally advanced sq uamous cell carcinoma of the head and neck
Key Publications on NACT and Targeted therapies in head and neck cancer
Chairpersons :
Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath
Reviewer :
Vijay Patil